Benzinga's Top Downgrades

by Lisa Levin, Benzinga Editor

November 25, 2016 9:19 AM | 1 min read | Make a Comment

Jefferies downgraded Headwaters Inc HW from Buy to Hold. Headwaters shares rose 0.19 percent to close at $23.57 on Wednesday.
Analysts at BMO Capital downgraded Eli Lilly and Co LLY from Outperform to Market Perform. The price target for Eli Lilly has been lowered to $64. Eli Lilly shares rose 0.16 percent to $68.11 in pre-market trading.
SunTrust Robinson Humphrey downgraded Juno Therapeutics Inc JUNO from Buy to Hold. The price target for Juno Therapeutics has been lowered from $48 to $25. Juno Therapeutics shares rose 1.95 percent to $23.00 in pre-market trading.
Atlantic Equities downgraded Eli Lilly and Co LLY from Overweight to Neutral. Eli Lilly shares closed at $68.00 on Wednesday.